Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain

NCT04930887 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Craniofacial Pain
Migraine
Cluster Headache
Trigeminal Autonomic Cephalgia
Sphenopalatine Ganglion Neuralgia
Paroxysmal Hemicrania

Interventions

DRUG: Exparel (Bupivacaine Liposome)
DRUG: Saline

Sponsor

Stanford University